The drug patents expired in India in July 2022, which has triggered a wave of generic launches and steep price corrections across the market.

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott and MSD Pharmaceuticals announced a distribution pact for oral anti-diabetic medicines like Januvia, Janumet, and ...

The high-potent oral solid dosage contract manufacturing market is gaining remarkable traction due to rising demand for safe and effective high-potency medications. As more pharmaceutical companies ...

The $7.4 billion deal between Purdue Pharma and all 50 U.S. states is a big step in the opioid crisis court cases. The agreement, made in a federal court for bankruptcy, plans to ...

Attorney General Kwame Raoul and a coalition of 55 attorneys general reached a $7.4 billion settlement with Purdue Pharma and the Sackler family over the opioid crisis.

All 50 states, the District of Columbia, and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, ...

Thailand’s pharmaceutical industry continues to face multiple challenges, particularly its heavy reliance on imported active ...

Cardinal Health will achieve $10 billion in adjusted free cash flow over the next three years. It has already increased its ...

Back in January, the B.C. Supreme Court certified the province's class-action lawsuit against opioid manufacturers and ...